SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-068277
Filing Date
2023-12-05
Accepted
2023-12-05 17:15:28
Documents
13
Period of Report
2023-12-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K olma-20231205.htm   iXBRL 8-K 56763
2 EX-99.1 olma-ex99_1.htm EX-99.1 27207
  Complete submission text file 0000950170-23-068277.txt   210839

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT olma-20231205_lab.xml EX-101.LAB 13466
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT olma-20231205_pre.xml EX-101.PRE 9886
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT olma-20231205.xsd EX-101.SCH 2448
7 EXTRACTED XBRL INSTANCE DOCUMENT olma-20231205_htm.xml XML 4749
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 231467573
SIC: 2834 Pharmaceutical Preparations